Author Question: The board of directors of Streamlined Airlines has declared a dividend of 4,300,000. The company has ... (Read 98 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
The board of directors of Streamlined Airlines has declared a dividend of 4,300,000. The company has 400,000 shares of preferred stock that pay 0.70 per share and 2,750,000 shares of common stock. After finding the amount of dividends due the preferred shareholders, calculate the dividend per share of common stock. (Round your answer to the nearest cent if necessary)
 A) 11.50
  B) 1.46
  C) 1.92
  D) 1.79

Question 2

Myerson borrowed 8,500 at 9 ordinary interest for 200 days. After 120 days, he made a partial payment of 4,000. What is the final amount due on the loan?
 A) 4,711.11
  B) 4,486.67
  C) 4,656.93
  D) 4,850.10



qytan

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library